Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 8.9 Million
14/05/2024 06:31
May 14 (Reuters) - PharmaSGP Holding Q1 revenue EUR 30.1 million. * Q1 adjusted EBITDA margin 29.4% * Q1 EBITDA EUR 8.7 million * Q1 EBITDA margin 28.7% * outlook FY revenue EUR 107-112 million
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million